Gene Editing: A Step Change in Biopharmaceutical Manufacturing

The natural characteristics of Chinese hamster ovary (CHO) cells have contributed to their use as the dominant expression platform in biomanufacturing. To increase the capabilities of these host systems, fundamental improvements to the CHO cell line are needed, which is where we believe that gene editing can offer a step change in biopharmaceutical manufacturing.

Fill out the form below to read the complete technology review now.



Leave a Reply